Back to search
FDAFDA · Food and drugs·Recall number D-396-2014

Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98

Published January 8, 2014 · Recall initiated: November 26, 2013

Summary

FDA records drug Class II recall D-396-2014, published January 8, 2014 and initiated November 26, 2013. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 10,512 bottles; Lot: Lot#: 32900349B, Exp: 12/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: There is a potential for broken tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide and Puerto Rico, American Samoa, Virgin Islands, and Canal Zone
Lot
Lot#: 32900349B, Exp: 12/2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98 recalled?

Yes. FDA published recall D-396-2014 on January 8, 2014. Reported hazard: Failed Tablet/Capsule Specifications: There is a potential for broken tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter